Hyloris publie son rapport annuel 2022 et ses objectifs ESG
28 avr. 2023 01h00 HE
|
Hyloris Pharmaceuticals SA
Publication du rapport annuel de l'exercice 2022Objectifs environnementaux, sociaux et de gouvernance, exposés dans le rapport initial sur ESGAssemblée Générale des actionnaires le mardi 13 juin 2023 ...
Hyloris releases Annual Report 2022, including ESG objectives
28 avr. 2023 01h00 HE
|
Hyloris Pharmaceuticals SA
Publication of the annual report for financial year 2022Environmental, Social and Governance objectives disclosed in initial report on ESGAnnual Shareholders Meeting on Tuesday, 13th of June 2023 ...
Aesthetic Medical International to Announce FY2022 Annual Report on April 21, 2023
14 avr. 2023 07h00 HE
|
Aesthetic Medical International Holdings Group Limited
SHENZHEN, China, April 14, 2023 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in...
K92 Mining Announces Strong 2022 Q4 and Annual Financial Results – Record Cash Balance, Revenue, Ore Mined and Ore Processed; Cash Cost and AISC Better Than Guidance
30 mars 2023 07h00 HE
|
K92 Mining Inc.
VANCOUVER, British Columbia, March 30, 2023 (GLOBE NEWSWIRE) -- K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) is pleased to announce financial results for the three and twelve...
HOOPP maintains strong funded status in challenging year: Improves benefits and keeps contribution levels unchanged
17 mars 2023 07h00 HE
|
Healthcare of Ontario Pension Plan
TORONTO, March 17, 2023 (GLOBE NEWSWIRE) -- Despite a very challenging year for the markets, HOOPP maintained a strong funded status of 117%. Funded status is one of the most important indicators of...
Hyloris présente ses résultats annuels pour 2022 et ses perspectives d’avenir
15 mars 2023 14h03 HE
|
Hyloris Pharmaceuticals SA
Solides progrès en R&D ainsi que d’attrayants accords commerciaux, y compris des contrats de licence supplémentaires pour l'acide tranexamique RTUAutorisation de marché attendue pour Maxigesic® IV...
Hyloris reports full year results for 2022 & provides business outlook
15 mars 2023 14h03 HE
|
Hyloris Pharmaceuticals SA
Strong R&D progress & attractive commercial deals, including additional Tranexamic Acid RTU out-licensing dealsPotential U.S. market approval for Maxigesic® IV in H2 2023Promising new product...
Black Diamond Reports Fourth Quarter and Year-End Results and Declares Dividend
02 mars 2023 18h44 HE
|
Black Diamond Group Limited
CALGARY, Alberta, March 02, 2023 (GLOBE NEWSWIRE) -- Black Diamond Group Limited ("Black Diamond", the "Company" or "we"), (TSX:BDI), a leading provider of space rental and workforce accommodation...
PHX Energy Announces Strongest Fourth Quarter and Year End Results In Its History
28 févr. 2023 19h10 HE
|
PHX Energy Services Corp.
CALGARY, Alberta, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Fourth Quarter Highlights For the three-month period ended December 31, 2022, PHX Energy generated consolidated revenue of $157.8 million, the...
Eramet : Année record avec un EBITDA supérieur à 1,5 Md€ et un très fort désendettement
22 févr. 2023 12h30 HE
|
Eramet SA
Paris, le 22 février 2023, 18h30 COMMUNIQUE DE PRESSE Eramet : Année record avec un EBITDA supérieur à 1,5 Md€ et un très fort désendettement EBITDA1 à 1,5 Md€ et EBITDA ajusté1,2 à 1,9 Md€...